Using mouse neuroblastoma cell lines, the administration of ketamine provided an anti-inflammatory effect on the lipopolysaccharide (LPS)-induced production of TNF-α through the inhibition of NF-κB and inducible nitric oxide synthase pathways [79]. Here, NFKB1 is linked to neuroblastoma.